About
Technology
Issues
FAQ
Links
Official Page
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.